# Post-stroke Neural Plasticity With Atomoxetine

> **NCT02788357** · PHASE2 · COMPLETED · sponsor: **Lumy Sawaki** · enrollment: 12 (actual)

## Conditions studied

- Atomoxetine Hydrochloride
- Placebos

## Interventions

- **DRUG:** Atomoxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02788357
- **Lead sponsor:** Lumy Sawaki
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2012-12
- **Final completion:** 2014-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02788357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02788357, "Post-stroke Neural Plasticity With Atomoxetine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02788357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*